Bhanvi Satija and Reuters 13 hours in the past FILE – An indication for Eli Lilly & Co. stands outdoors their company headquarters in Indianapolis on April 26, 2017. Zepbound, a brand new model of the corporate’s common diabetes therapy Mounjaro will be bought as a weight-loss drug, U.S. regulators introduced Wednesday, Nov. 8, 2023....

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Order On: Healthy4Sure Store.

2025 © All Rights Reserved.